Generated SecPen_NY-ESO-1_ubiquitin-pulsed dendritic cell cancer vaccine elicits stronger and specific T cell immune responses
Dendritic cell-based cancer vaccines (DC vaccines) have been proved efficient and safe in immunotherapy of various cancers, including melanoma, ovarian and prostate cancer. However, the clinical responses were not always satisfied. Here we proposed a novel strategy to prepare DC vaccines. In the pre...
Saved in:
Main Authors: | Yunkai Yang (Author), Xiaohan Guo (Author), Bo Hu (Author), Peng He (Author), Xiaowu Jiang (Author), Zuohuan Wang (Author), Huaxing Zhu (Author), Lina Hu (Author), Minghua Yu (Author), Meiqing Feng (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2021-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ubiquitin-Specific Protease 2 Modulates the Lipopolysaccharide-Elicited Expression of Proinflammatory Cytokines in Macrophage-like HL-60 Cells
by: Hiroshi Kitamura, et al.
Published: (2017) -
The Stronger Influence
by: Young, F. E. Mills (Florence Ethel Mills), 1875- -
Regulatory T cells in human lymphatic filariasis: stronger functional activity in microfilaremics.
by: Linda J Wammes, et al.
Published: (2012) -
Torchy, Private Sec.
by: Ford, Sewell, 1868-1946; Lincoln, F. Foster (Frederic Foster) [Illustrator] -
The potential of the CMB305 vaccine regimen to target NY-ESO-1 and improve outcomes for synovial sarcoma and myxoid/round cell liposarcoma patients
by: Seth M. Pollack
Published: (2018)